Case Western Reserve University School of Medicine identifies a potential new approach to address the opioid overdose epidemic–which has devastated families and communities nationally. Semaglutide was found to lower opioid overdoses in people with opioid-use disorder (OUD) and type 2 diabetes (T2D).
